Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$134,770,826
-$20,867,109 QoQ
Shares Held
447,699
-4.8% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#44
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. ALNY ranks #13 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,770,826 | 447,699 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $155,637,935 | 470,390 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $313,198,281 | 787,623 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $325,589,472 | 714,012 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $196,088,023 | 601,331 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $123,753,944 | 458,314 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $97,451,045 | 414,139 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $105,329,061 | 382,973 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $70,306,218 | 289,326 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $35,497,959 | 237,524 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $28,889,127 | 150,928 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $26,617,066 | 150,294 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $28,561,276 | 150,370 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $32,210,453 | 160,795 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $38,224,812 | 160,845 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $31,884,485 | 159,295 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,768,642 | 156,110 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $31,297,629 | 191,669 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $35,663,860 | 210,307 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $28,256,359 | 149,655 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $611,118 | 3,605 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $436,275 | 3,090 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $465,291 | 3,580 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $18,238,583 | 125,265 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $18,369,194 | 124,024 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,545,075 | 124,438 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||